{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:12:18Z","timestamp":1791475938519,"version":"4.3.4"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128522","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T14:07:47Z","timestamp":1437142067000},"page":"e0128522","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00549523","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Douglas","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Goggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Gerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nceba","family":"Gqaleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Syce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinton","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Folk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"key":"ref1","unstructured":"Statistics South Africa. Mid-year population estimates 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/beta2.statssa.gov.za\/publications\/P0302\/P03022013.pdf\" xlink:type=\"simple\">http:\/\/beta2.statssa.gov.za\/publications\/P0302\/P03022013.pdf<\/ext-link>"},{"key":"ref2","unstructured":"Department of Health, Republic of South Africa. The South African antiretroviral treatment guidelines 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sahivsoc.org\/upload\/documents\/2013%20ART%20Guidelines-Short%20Combined%20FINAL%20draft%20guidelines%2014%20March%202013.pdf\" xlink:type=\"simple\">http:\/\/www.sahivsoc.org\/upload\/documents\/2013%20ART%20Guidelines-Short%20Combined%20FINAL%20draft%20guidelines%2014%20March%202013.pdf<\/ext-link>"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e3181a44ef2","article-title":"Loss to care and death before antiretroviral therapy in Durban, South Africa","volume":"51","author":"IV Bassett","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.aids.0000366081.91192.1c","article-title":"Who starts antiretroviral therapy in Durban, South Africa?\u2026 not everyone who should","author":"IV Bassett","year":"2010","journal-title":"AIDS"},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/QAD.0b013e32834b6464","article-title":"Antiretroviral therapy refusal among newly diagnosed HIV-infected adults","volume":"25","author":"IT Katz","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0b013e3181ff0bdc","article-title":"Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa","volume":"56","author":"MD Nglazi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref7","unstructured":"Assembly of Heads of State and Government. Decisions and declarations. Lusaka: Assembly of Heads of State and Government, Thirty-seventh Ordinary Session \/ Fifth Ordinary Session of the AEC; 2001. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.au2002.gov.za\/docs\/summit_council\/ahg.pdf\" xlink:type=\"simple\">http:\/\/www.au2002.gov.za\/docs\/summit_council\/ahg.pdf<\/ext-link>. Accessed 2015 May 9."},{"issue":"9694","key":"ref8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(09)61261-7","article-title":"Traditional Health Practitioners in South Africa","volume":"374","author":"K. Peltzer","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"ref9","first-page":"175","article-title":"Utilization and practice of traditional\/complementary\/alternative medicine (TM\/CAM) in South Africa","volume":"6","author":"K Peltzer","year":"2009","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2458-8-255","article-title":"Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa","volume":"8","author":"K Peltzer","year":"2008","journal-title":"BMC Public Health"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/09540120701767216","article-title":"Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care","volume":"20","author":"RA Littlewood","year":"2008","journal-title":"AIDS Care"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jep.2008.08.003","article-title":"A review of the taxonomy, ethnobotany, chemistry and pharmacology of <italic>Sutherlandia frutescens<\/italic> (Fabaceae)","volume":"119","author":"BE Van Wyk","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0006-3223(03)00323-8","article-title":"HIV disease progression: depression, stress, and possible mechanisms","volume":"54","author":"J Leserman","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref14","unstructured":"Seier JV, Mdhluli M, Dhansay MA, Loza J, Laubscher R. A toxicity study of Sutherlandia leaf powder (<italic>Sutherlandia microphylla<\/italic>) consumption. Final report: April 2002. Medical Research Council of South Africa and National Research Foundation. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sahealthinfo.co.za\/traditionalmeds\/cancerbush2.pdf\" xlink:type=\"simple\">http:\/\/www.sahealthinfo.co.za\/traditionalmeds\/cancerbush2.pdf<\/ext-link>. Accessed 2015 May 9."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pctr.0020016","article-title":"A randomized, double-blind, placebo-controlled trial of <italic>Lessertia frutescens<\/italic> in healthy adults","volume":"2","author":"Q Johnson","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"ref16","unstructured":"World Health Organization, Regional Office for Africa. Progress report on a decade of traditional medicine in the African region. 2011. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.afro.who.int\/index.php?option=com_docman&task=doc\" xlink:type=\"simple\">www.afro.who.int\/index.php?option=com_docman&amp;task=doc<\/ext-link>. Accessed 2015 May 9."},{"key":"ref17","unstructured":"South African National AIDS Council. National Strategic Plan for HIV and AIDS, STIs and TB 2012\u20132016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sanac.org.za\/nsp\/the-national-strategic-plan\" xlink:type=\"simple\">www.sanac.org.za\/nsp\/the-national-strategic-plan<\/ext-link>. Accessed 2015 May 9."},{"key":"ref18","unstructured":"Department of Health, Republic of South Africa. The 2010 national antenatal sentinel HIV and syphilis prevalence survey in South Africa. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.gov.za\/sites\/www.gov.za\/files\/hiv_aids_survey_0.pdf\" xlink:type=\"simple\">http:\/\/www.gov.za\/sites\/www.gov.za\/files\/hiv_aids_survey_0.pdf<\/ext-link>. Accessed 2015 May 9."},{"issue":"12","key":"ref19","first-page":"1375","article-title":"Randomized Phase II Clinical Trials","volume":"69","author":"R Simon","year":"1985","journal-title":"Cancer Treatment Reports"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/sim.1150","article-title":"Early selection in a randomized phase II clinical trial","volume":"21","author":"S Steinberg","year":"2002","journal-title":"Statistics in Medicine"},{"key":"ref21","unstructured":"National Center for Complementary and Alternative Medicine. NCCAM Policy: Natural Product Integrity (2013). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/nccam.nih.gov\/research\/policies\/naturalproduct.htm\" xlink:type=\"simple\">http:\/\/nccam.nih.gov\/research\/policies\/naturalproduct.htm<\/ext-link>. Accessed 2015 May 9."},{"key":"ref22","unstructured":"Medicines Control Council, Department of Health, Republic of South Africa. Complementary medicines\u2013quality, safety and efficacy (2013). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pharmacos.co.za\/downloads\/7%2001_CAMs_QSE_Aug11_v1_5_draft(2).pdf\" xlink:type=\"simple\">http:\/\/www.pharmacos.co.za\/downloads\/7%2001_CAMs_QSE_Aug11_v1_5_draft(2).pdf<\/ext-link>. Accessed 2015 May 9."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1018451930750","article-title":"Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)","volume":"6","author":"AW Wu","year":"1997","journal-title":"Quality of Life Research"},{"key":"ref24","first-page":"273","article-title":"The translation and cultural adaptation of patient-reported outcome measures for a clinical study involving Traditional Health Providers and biomedically trained practitioners","volume":"17","author":"K Goggin","year":"2010","journal-title":"Alternation"},{"key":"ref25","first-page":"17","article-title":"Does L-canavanine ingestion induce murine SLE? Paradoxical effects on survival of BALB\/c","volume":"5","author":"DL Brown","year":"2001","journal-title":"Journal of Nutritional Immunology"},{"key":"ref26","unstructured":"National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events version 1, December 2004, clarification August 2009. National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events version 1, December 2004, clarification August 2009. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf\" xlink:type=\"simple\">http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf<\/ext-link>. Accessed 2014 September 21."},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-200501030-00013","article-title":"Impact of African herbal medicines on antiretroviral metabolism","volume":"19","author":"E Mills","year":"2005","journal-title":"AIDS"},{"issue":"1\u20132","key":"ref28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2011.04.051","article-title":"Effect of short term and chronic administration of <italic>Sutherlandia frutescens<\/italic> on pharmacokinetics of nevirapine in rats","volume":"413","author":"M Minocha","year":"2011","journal-title":"Int J Pharm"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2891-4-19","article-title":"African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology","volume":"4","author":"E Mills","year":"2005","journal-title":"Nutr J"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2004.05.024","article-title":"The antioxidant potential of <italic>Sutherlandia frutescens<\/italic>","volume":"95","author":"AC Fernandes","year":"2004","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ptr.1719","article-title":"Antibacterial and antioxidant activity of <italic>Sutherlandia frutescens<\/italic> (Fabaceae), a reputed anti-HIV\/AIDS phytomedicine","volume":"19","author":"DR Katerere","year":"2005","journal-title":"Phytother Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"e89748","DOI":"10.1371\/journal.pone.0089748","article-title":"<italic>Sutherlandia frutescens<\/italic> Ethanol Extracts Inhibit Oxidative Stress and Inflammatory Responses in Neurons and Microglial Cells","volume":"9","author":"J Jiang","year":"2014","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1472-6882-14-271","article-title":"Antioxidant potential of <italic>Sutherlandia frutescens<\/italic> and its protective effects against oxidative stress in various cell cultures","volume":"14","author":"S Tobwala","year":"2014","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","article-title":"Mechanisms of action of isoniazid","volume":"62","author":"GS Timmins","year":"2006","journal-title":"Mol Microbiol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/ptr.2830","article-title":"<italic>Sutherlandia frutescens<\/italic> limits the development of insulin resistance by decreasing plasma free fatty acid levels","volume":"23","author":"J MacKenzie","year":"2009","journal-title":"Phytother Res"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jep.2008.03.019","article-title":"The influence of <italic>Sutherlandia frutescens<\/italic> on adrenal steroidogenic cytochrome P450 enzymes","volume":"118","author":"D Prevoo","year":"2008","journal-title":"J Ethnopharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:19:59Z","timestamp":1540012799000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128522"}},"subtitle":[],"editor":[{"given":"T. Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128522","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]}}}